Gelsolin-related familial amyloidosis, Finnish type (FAF), and its variants found worldwide

References

• Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1969; 1: 314–324
   PubMedGoogle Scholar
• McKusick V A. Mendelian Inheritance in Man. Johns Hopkins University Press, Baltimore 1990; 58–59
   Google Scholar
• Maury C PJ, Alii K, Baumann M. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsoline. FEBS Lett 1990; 260: 85–87
   PubMed Web of Science ®Google Scholar
• Haltia M, Prelli F, Ghiso J, Kiuru S, Somer H, Palo J, Frangione B. Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Commun 1990; 167: 927–932
   PubMed Web of Science ®Google Scholar
• Husby G, Araki A, Benditt E P, Benson M, Cohen A, Frangione B, Glenner G G, Natvig J B, Westermark P. The 1990 guidelines for nomenclature and classification of amyloid and amyloidosis. Amyloid and Amyloidosis 1990, J B Natvig, O Forre, G Husby, A Husebekk, B Skogen, K Sletten, P Westermark. Kluwer Academic Publishers, Dordrecht 1991; 7–11
   Google Scholar
• Meretoja J, Teppo L. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Report of three cases. Acta Path Microbiol Scand [Sect A] 1971; 79: 432–440
   PubMedGoogle Scholar
• Meretoja J. Comparative histopathological and clinical findings in eyes with lattice corneal dystrophy of two different types. Ophthalmologica 1972; 165: 15–37
   PubMed Web of Science ®Google Scholar
• Meretoja J, Jokinen E J, Collan Y, Lahdevirta J. Renal biopsy findings in familial amyloidosis with corneal lattice dystrophy. Acta Path Microbiol Scand [Sect A] 1972; 80: 228–238
   Google Scholar
• Kaunisto N. Lattice dystrophy of the cornea. Acta Ophthalmologica 1973; 51: 335–352
   Google Scholar
• Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet 1973; 4: 173–185
   PubMed Web of Science ®Google Scholar
• Meretoja J, Tarkkanen A. Pseudoexfoliation syndrome in familial systemic amyloidosis with lattice corneal dystrophy. Ophthalmic Res 1975; 7: 194–203
   Google Scholar
• Meretoja J. Tautiperintoamme: suomalainen amyloiditauti (The Finnish amyloid disease representing our disease inheritage). Suomen ladkarilehti (J Finn Med Assoc) 1976; 31: 2234–2236, (in Finnish)
   Google Scholar
• Collan Y, Meretoja J. Inherited systemic amyloidosis (Finnish type): Ultrastructure of the skin. Ann Clin Res 1978; 10: 43–47
   PubMedGoogle Scholar
• Rintala A E, Alanko A, Makinen J, Nordstrom R, Salo H. Primary hereditary systemic amyloidosis (Meretoja's syndrome): clinical features and treatment by plastic surgery. Scand J Plast Reconstr Surg 1988; 22: 141–145
   Web of Science ®Google Scholar
• Haltia M, Ghiso J, Prelli F, Gallo G, Kiuru S, Somer H, Palo J, Frangione B. Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. Am J Pathol 1990; 136: 1223–1228
   PubMed Web of Science ®Google Scholar
• Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990; 172: 1865–1867
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Kere J, Tolvanen Rand de la Chapelle A. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Lett 1990; 276: 75–77
   PubMed Web of Science ®Google Scholar
• Hiltunen T, Kiuru S, Hongell V, Helio T, Palo J, Peltonen L. Finnish type of familial amyloidosis: cosegregation of ASP187→ASN mutation of gelsolin with the disease in three large families. Am J Hum Genet 1991; 49: 522–528
   PubMed Web of Science ®Google Scholar
• de la Chapelle A, Kere J, Sack G H, Jr, Tolvanen R, Maury C PJ. Familial amyloidosis, Finnish type: G654→A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1992; 1: 898–901
   Google Scholar
• de la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury C PJ, Kere J. Gelsolin-derived familial amyloidosis caused by asparagine or tyrosine substitution for aspartic acid at residue 187. Nature Genet 1992; 2: 157–160
   PubMed Web of Science ®Google Scholar
• Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation-at codon 187- in familial amyloidosis, Finnish: DNA-diagnostic assay. Am J Med Genet 1992; 42: 357–359
   PubMed Web of Science ®Google Scholar
• Kiuru S. Familial amyloidosis of the Finnish type (FAF)- A clinical study of 30 patients. Acta Neurol Scand 1992; 86: 346–353
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Kere J, Tolvanen R, de la Chapelle A. Homozygosity for the Asnl87 gelsolin mutation in Finnish-type familial amyloidosis is associated with severe renal disease. Genomics 1992; 13: 902–903
   PubMed Web of Science ®Google Scholar
• Paunio T, Kiuru S, Hongell V, Mustonen E, Syvanen A C, Bengtström M, Palo J, Peltonen L. Solid-phase minisequencing test reveals Aspl87→ Asn (G654→A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992; 13: 237–239
   PubMed Web of Science ®Google Scholar
• Kivela T, Tarkkanen A, McLean I, Ghiso J, Frangione B, Haltia M. Immunohistochemical analysis of lattice corneal dystrophies types I and II. Br J Ophthalmol 1993; 77: 799–804
   PubMedGoogle Scholar
• Kiuru S, Seppalainen A M. Neuropathy in familial amyloidosis, Finnish type (FAF): Electrophysiological studies. Muscle Nerve 1994; 17: 299–304
   PubMed Web of Science ®Google Scholar
• Kiuru S, Matikainen E, Kupari M, Haltia M, Palo J. Autonomic nervous system and cardiac involvement in familial amyloidosis, Finnish type (FAF). J Neurol Sci 1994; 126: 40–48
   PubMed Web of Science ®Google Scholar
• Kivelä T, Tarkkanen A, Frangione B, Ghiso J, Haltia M. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome. Invest Ophthalmol Vis Sci 1994; 35: 3759–3769
   PubMed Web of Science ®Google Scholar
• Kiuru S, Seppalainen A M, Salonen O, Hokkanen L, Somer H, Palo J. CNS abnormalities in patients with familial amyloidosis of the Finnish type (FAF). Amyloid: Int J Exp Clin Invest 1995; 2: 22–30
   Web of Science ®Google Scholar
• Paunio T, Sunada Y, Kiuru S, Makishita H, Ikeda S, Weissenbach J, Palo J, Peltonen L. Haplotype analysis in gelsolin-related amyloidosis reveals independent origin of identical mutation (G645A) of gelsolin in Finland and Japan. Hum Mut 1995; 6: 60–65
   PubMed Web of Science ®Google Scholar
• Winkelman J E, Delleman J W, Ansink B JJ. Ein hereditares Syndrom, bestehend aus peripherer Polyneuropathie, Hautveranderungen und gittriger Dystrophic der Hornhaut. Klin Mbl Augenhk 1971; 159: 618–623
   PubMedGoogle Scholar
• Boysen G, Galassi G, Kamieniecka Z, Schlaeger J, Trojaborg W. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. J Neurol Neurosurg Psychiatry 1979; 42: 1020–1030
   PubMed Web of Science ®Google Scholar
• Sack G H, Dumars K W, Gummerson K S, Law A, McKusick V A. Three forms of dominant amyloid neuropathy. Johns Hopkins Med 1981; 149: 239–247
   PubMedGoogle Scholar
• Purcell J J, Jr, Rodrigues M, Chishti I, Riner R N, Dooley J M. Lattice corneal dystrophy associated with familial systemic amyloidosis (Meretoja's syndrome). Ophthalmology 1983; 90: 1512–1517
   PubMed Web of Science ®Google Scholar
• Starck T, Kenyon K R, Hanninen L A, Beyer-Machule C, Fabian R, Gorn R A, McMullan F D, Baum J, McAdam K PWJ. Clinical and histopathologic studies of two families with lattice corneal dystrophy and familial systemic amyloidosis (Meretoja syndrome). Ophthalmology 1991; 98: 1197–1206
   PubMedGoogle Scholar
• Hanninen L A, Gilbard J P, Wang S J, Kenyon K R. Familial systemic amyloidosis with lattice corneal dystrophy. Proceedings of the VIIth Congress of the European Society of Ophthalmology, H E Henkes, R Ahonen, K Karjalainen. The Society, Helsinki 1985; 438–440
   Google Scholar
• Darras B T, Adelman L S, Mora J S, Bodziner R A, Munsat T L. Familial amyloidosis with cranial neuropathy and corneal lattice dystrophy. Neurology 1986; 36: 432–435
   PubMedGoogle Scholar
• Steiner R D, Paunio T, Uemichi T, Evans J P, Benson M. Asp 187Asn mutation of gelsolin in an American kindred with familial amyloidosis, Finnish type (FAF). Hum Genet 1995; 95: 327–330
   PubMed Web of Science ®Google Scholar
• Sunada Y, Shimizu T, Nakase H, Ohta S, Asaoka T, Amano S, Sawa M, Kagawa Y, Kanazawa I, Mannen T. Inherited amyloid polyneuropathy type IV (gelsolin variant) in a Japanese family. Ann Neurol 1993; 33: 57–62
   PubMed Web of Science ®Google Scholar
• Yazaki M, Makishita H, Yazawa M, Ikeda S-I, Yanagisawa N. Clinicopathological study of type IV familial amyloid polyneuropathy in Japan. Amyloid and Amyloidosis 1993, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing, New York 1994; 688–690
   Google Scholar
• Akiya S, Nishio Y, Ibi K, Uozumi H, Takahashi H, Hamada T, Onishi A, Ischiguchi H, Hoshii Y, Nakazato M. Lattice corneal dystrophy type II associated with familial amyloid polyneuropathy type IV. Ophthalmology 1996; 103: 1106–1110
   PubMed Web of Science ®Google Scholar
• Makishita H, Ikeda S, Yazaki M, Yamane M, Yomoto K, Maury C PJ, Yanagisawa N. Postmortem pathological findings in a Japanese patient with familial amyloidosis, Finnish type (FAF). Amyloid: Int J Exp Clin Invest 1996; 3: 134–139
   Web of Science ®Google Scholar
• Klaus E, Freyberger E, Kavka G, Vodicka F. Familiares Vorkommen von bulbarparalytischer Form der amyotrophischen Lateralsklerose mit gittriger Hornhautdystrophie und Cutis hyperelastica bei drei Schwestern. Psychiatr Neurol 1959; 138: 79–97
   PubMedGoogle Scholar
• Gorevic P D, Munoz P C, Gorgone G, Purcell J J, Jr, Rodriques M, Ghiso J, Levy E, Haltia M, Frangione B. Amyloidosis due to a mutation of the gelsolin gene in an American family with corneal lattice dystrophy type II. New Engl J Med 1991; 325: 1780–1785
   PubMed Web of Science ®Google Scholar
• Vrabec F R. Etude neurohistologique d'un cas de dystrophic grillagee de lacornee. Ophthalmologica 1957; 133: 160–169
   PubMedGoogle Scholar
• Miller C A, Krachmer J H. Epithelial and stromal dystrophies. The Cornea, H E Kaufman, B A Barron, M B McDonald, S R Waltman. Churchill Livingstone, New York 1988; 404–409
   Google Scholar
• Gorevic P D, Rodriques M M. Ocular amyloidosis. Am J Ophthalmol 1994; 117: 529–532
   PubMed Web of Science ®Google Scholar
• Haltia M, Ghiso J, Wisniewski T, Kiuru S, Miller D, Frangione B. Gelsolin variant and β-amyloid co-occur in a case of Alzheimer's with Lewy bodies. Neurobiol Aging 1991; 12: 313–316
   PubMedGoogle Scholar
• Paunio T, Kiuru S, Karonen S L, Palo J, Peltonen L. Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel). Amyloid: Int J Exp Clin Invest 1994; 1: 80–89
   Web of Science ®Google Scholar
• Donders P C, Blanksma L J. Meretoja syndrome. Lattice dystrophy of the cornea with hereditary generalized amyloidosis. Ophthalmologica 1979; 178: 173–180
   PubMedGoogle Scholar
• Ghiso J, Haltia M, Prelli F, Novello J, Frangione B. Gelsolin variant (Asn-187) in familial amyloidosis, Finnish type. Biochem J 1990; 272: 827–830
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Baumann M. Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1990; 1096: 84–86
   PubMed Web of Science ®Google Scholar
• Maury C PJ. Immunohistochemical localization of amyloid in Finnish hereditary amyloidosis with antibodies to gelsolin peptides. Lab Invest 1991; 64: 400–404
   PubMed Web of Science ®Google Scholar
• Rodriques M M, Rajagopalan S, Jones K, Nirankari V, Wisniewski T, Frangione B, Gorevic P D. Gelsolin immunoreactivity in corneal amyloid, wound healing, and macular and granular dystrophies. Am J Ophthalmol 1993; 115: 644–652
   PubMedGoogle Scholar
• Loeffler K U, Edvard D P, Tso M OM. An immunohistochemical study of gelsolin immunoreactivity in corneal amyloidosis. Am J Ophthalmol 1992; 11: 547–554
   Google Scholar
• Meretoja J. Inherited systemic amyloidosis with corneal lattice dystrophy and cranial neuropathy. Amyloidosis, O Wegelius, A Pasternack. Academic Press, London 1976; 195–209
   Google Scholar
• Tanaka M, Mullauer L, Ogiso Y, Fujita H, Moriya S, Furuuchi K, Harabayashi T, Shinohara N, Koyanagi T, Kuzumaki N. Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Research 1995; 55: 3228–3232
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D J, Stossel T P, Orkin S H, Mole J E, Colten H R, Yin H L. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986; 323: 455–458
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D J, Westbrook C A, Bruns G AP, Morton C. Localization of gelsolin proximal to ABL on chromosome 9. Am J Hum Genet 1988; 42: 565–572
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D J, Mehl R, Yin H L. Genomic organisation and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol 1988; 106: 375–384
   PubMed Web of Science ®Google Scholar
• Yin H, Kwiatkowski D J, Mole J E, Cole F S. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 1984; 259: 5271–5276
   PubMed Web of Science ®Google Scholar
• Paunio T, Kangas H, Kalkkinen N, Haltia M, Palo J, Peltonen J. Towards understanding the pathogenetic mechanisms in gelsolin-related amyloidosis: in vitro expession reveals an abnormal gelsolin fragment. Hum Mol Genet 1994; 3: 2223–2229
   PubMed Web of Science ®Google Scholar
• Kangas H, Paunio T, Kalkkinen N, Jalanko A, Peltonen L. In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. Hum Mol Genet 1996; 5: 1237–1243
   PubMed Web of Science ®Google Scholar
• Maury C PJ. Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest 1991; 87: 1195–1199
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Nurmiaho-Lassila E L, Rossi H. Amyloid fibril formation in gelsolin-derived amyloidosis. Definition of the amyloidogenic region and evidence of accelerated amyloid formation of mutant Asn-187 and Tyr-187 gelsolin peptides. Lab Invest 1994; 70: 558–564
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Nurmiaho-Lassila E L. Creation of amyloid fibrils from mutant ASN 187 gelsolin peptides. Biochem Biophys Res Commun 1992; 183: 227–231
   PubMed Web of Science ®Google Scholar
• Soto C, Castano E M, Prelli F, Kumar R A, Baumann M. Apolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer's, gelsolin and AA amyloids. FEBS Lett. 1995; 371: 110–114
   PubMed Web of Science ®Google Scholar
• McLaughlin P J, Gooch J T, Mannherz H G, Weeds A G. Structure of gelsolin segment 1-actin complex and the mechanism of filament severing. Nature 1993; 364: 685–692
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Rossi H. Demonstration of a circulating 65 K gelsolin variant specific for familial amyloidosis, Finnish type. Biochem Biophys Res Commun 1993; 191: 41–44
   PubMed Web of Science ®Google Scholar
• Sunada Y, Sakurai T, Nonomura Y, Kanazawa I. Abnormal gelsolin fragments in the plasma of patients with familial amyloidosis of the Finnish type. Amyloid and Amyloidosis 1993, R Kisilevsky, M D Benson, B Frangione, J Gauldie, T J Muckle, I D Young. Parthenon Publishing, New York 1994; 623–625
   Google Scholar
• Paunio T, Kangas H, Kiuru S, Jorma P, Peltonen L, Syvanen A C. Tissue distribution and levels of gelsolin mRNA in normal individuals and patients with gelsolin-related amyloidosis. FEBS Lett. 1997; 406: 49–55
   PubMed Web of Science ®Google Scholar
• Yin H L, Albrecht J H, Fattoum A. Identification of gelsolin, a Ca2+-dependent regulatory protein of actin gel-sol transformation, and its intracellular distribution in a variety of cells and tissues. J Cell Biol 1981; 91: 901–906
   PubMedGoogle Scholar
• Kwiatkowski D J, Mehl R, Izumo S, Nada-Ginard B, Yin H. Muscle is the major source of plasma gelsolin. J Biol Chem 1988; 263: 8239–8243
   PubMedGoogle Scholar
• Tanaka J, Kira M, Sobue K. Gelsolin is localized in neuronal growth cones. Dev Brain Res 1993; 76: 268–271
   PubMedGoogle Scholar
• Lena J Y, Legrand C H, Faivre-Sarrailh C, Sarlieve L L, Ferraz C, Rabid A. High gelsolin content of developing oligodendrocytes. Int J Devi Neuroscience 1994; 12: 375–386
   PubMedGoogle Scholar
• Tanaka J, Sobue K. Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J Neurosci 1994; 12: 375–386
   Google Scholar
• Schwartz S B, Higgins P J, Rajasekaran A K, Staiano-Coico L. Growth and differentiation of normal human keratinocytes in culture: modulation of gelsolin expression. J Burn Care Rehabil 1994; 15: 478–485
   PubMedGoogle Scholar
• Nodes B, Shackelford J E, Lebherz H G. Synthesis and secretion of serum gelsolin by smooth muscle tissue. J Biol Chem 1987; 262: 5422–5427
   PubMedGoogle Scholar
• Dißmann E, Hinssen H. Immunocytochemical localization of gelsolin in fibroplasts, myogenic cells, and isolated myofibrils. Eur J Cell Biol 1994; 63: 336–344
   PubMedGoogle Scholar
• Witke W, Sharpe A H, Hartwig J H, Azuma T, Stossel T P, Kwiatkowski D J. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell 1995; 81: 41–51
   PubMed Web of Science ®Google Scholar
• Hartwig J H, Bokoch G M, Carpenter C L, Jamney P A, Taylor L A, Toker A, Stossel T P. Thrombin receptor ligation and activated rac uncap actin filament barbed ends through phoshoinositide synthesis in permeabilized human platelets. Cell 1995; 82: 643–653
   PubMed Web of Science ®Google Scholar
• Chen P, Murphy-Ullrich J E, Wells A. A role for gelsolin in actuating epidermal growth factor receptor-mediated cell motility. J Cell Biol 1996; 134: 689–698
   PubMed Web of Science ®Google Scholar
• Lee W M, Galbraith R M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 1992; 326: 1335–1341
   PubMed Web of Science ®Google Scholar
• Way M, Weeds A. Nucleotide sequence of pig plasma gelsolin: comparison of protein sequence with human gelsolin and other actin-severing proteins shows strong homologies and evidence for large internal repeats. J Mol Biol 1988; 203: 1127–1133
   PubMed Web of Science ®Google Scholar
• Weeds A G, Gooch J, McLaughlin P, Maury C PJ. Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity. FEBS Lett 1993; 335: 119–123
   PubMed Web of Science ®Google Scholar